Business
Restart Life Closes Over-Subscribed Second Tranche Financing
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") announces that further to its news release dated November 12, 2025 and December 5, 2025, the Company has closed the over-subscribed second tranche of its non-brokered private placement for total gross proceeds of CDN$630,000 (the "Placement"). As announced on November 12, 2025, the company intended to raise a total of up to...
About this update from Restart Life Sciences Corp.
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") announces that further to its news release dated November 12, 2025 and December 5, 2025, the Company has closed the over-subscribed second tranche of its non-brokered private placement for total gross proceeds of CDN$630,000 (the "Placement"). As announced on November 12, 2025, the company intended to raise a total of up to CDN$1,000,000 however due to overwhelming interest in the company's objectives, the company has raised a total of CDN$1,130,000 in two tranches.","length":676,"tagName":"p"},{"type":"text","content":"Pursuant to the Second Tranche of the Private Placement, the Company has allotted and issued 6,300,000 units (the "Units") at a price of CDN$0.10 per Unit. Each Unit consists of one common share and one transferable common share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder to purchase one additional common share for a period of one (1) year at a price of CDN$0.10 per common share.","length":429,"tagName":"p"},{"type":"text","content":"In connection with the Placement, the Company issued 132,000 non-transferable finder warrants (each, a "Finder Warrant") to certain eligible arm's-length finders who introduced subscribers to the Placement. Each Finder Warrant entitles the holder to purchase one common share for a period of one (1) year at a price of CDN$0.10 per common share.","length":359,"tagName":"p"},{"type":"text","content":"The Company intends to use the proceeds from the Offering towards health food trials, potential acquisitions, and general working capital. All securities issued under the Placement are subject to a hold period of four months and one day expiring on April 18, 2026.","length":264,"tagName":"p"},{"type":"text","content":"About Restart Life Sciences Corp. Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life, please visit the Company's website at www.restartlife.co.","length":226,"tagName":"p"},{"type":"text","content":"On behalf of the Board of Directors Steve Loutskou Chief Executive Officer, Restart Life Sciences Corp. Tel: +1 (778) 819-0244 Email: hel...